Literature DB >> 22241097

NF1 microduplications: identification of seven nonrelated individuals provides further characterization of the phenotype.

Kimberly J Moles1, Gordon C Gowans, Satyanarayana Gedela, David Beversdorf, Arthur Yu, Laurie H Seaver, Roger A Schultz, Jill A Rosenfeld, Beth S Torchia, Lisa G Shaffer.   

Abstract

PURPOSE: Neurofibromatosis, type 1 (NF1) is an autosomal dominant disorder caused by mutations of the neurofibromin 1 (NF1) gene at 17q11.2. Approximately 5% of individuals with NF1 have a 1.4-Mb heterozygous 17q11.2 deletion encompassing NF1, formed through nonallelic homologous recombination (NAHR) between the low-copy repeats that flank this region. NF1 microdeletion syndrome is more severe than NF1 caused by gene mutations, with individuals exhibiting facial dysmorphisms, developmental delay (DD), intellectual disability (ID), and excessive neurofibromas. Although NAHR can also cause reciprocal microduplications, reciprocal NF1 duplications have been previously reported in just one multigenerational family and a second unrelated proband.
METHODS: We analyzed the clinical features in seven individuals with NF1 microduplications, identified among 48,817 probands tested in our laboratory by array-based comparative genomic hybridization.
RESULTS: The only clinical features present in more than one individual were variable DD/ID, facial dysmorphisms, and seizures. No neurofibromas were present. Three sets of parents were tested: one duplication was apparently de novo, one inherited from an affected mother, and one inherited from a clinically normal father.
CONCLUSION: This is the first report comparing the phenotypes of nonrelated individuals with NF1 microduplications. This comparison will allow for further definition of this emerging microduplication syndrome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22241097     DOI: 10.1038/gim.2011.46

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  6 in total

Review 1.  Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate.

Authors:  Frederik Holst
Journal:  World J Clin Oncol       Date:  2016-04-10

2.  Simple, rapid and inexpensive quantitative fluorescent PCR method for detection of microdeletion and microduplication syndromes.

Authors:  Martin Stofanko; Higgor Gonçalves-Dornelas; Pricila Silva Cunha; Heloísa B Pena; Angela M Vianna-Morgante; Sérgio Danilo Junho Pena
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

3.  Familial Lymphoproliferative Malignancies and Tandem Duplication of NF1 Gene.

Authors:  Gustavo Fernandes; Mirela Souto; Frederico Costa; Edite Oliveira; Bernardo Garicochea
Journal:  Case Rep Oncol Med       Date:  2014-12-14

Review 4.  The NF1 gene revisited - from bench to bedside.

Authors:  Yoon-Sim Yap; John R McPherson; Choon-Kiat Ong; Steven G Rozen; Bin-Tean Teh; Ann S G Lee; David F Callen
Journal:  Oncotarget       Date:  2014-08-15

5.  RNF135, RING finger protein, promotes the proliferation of human glioblastoma cells in vivo and in vitro via the ERK pathway.

Authors:  Yongjian Liu; Feng Wang; Yongsheng Liu; Yiqun Yao; Xiupeng Lv; Bin Dong; Jun Li; Siyang Ren; Yiwen Yao; Yinghui Xu
Journal:  Sci Rep       Date:  2016-02-09       Impact factor: 4.379

Review 6.  Emerging genotype-phenotype relationships in patients with large NF1 deletions.

Authors:  Hildegard Kehrer-Sawatzki; Victor-Felix Mautner; David N Cooper
Journal:  Hum Genet       Date:  2017-02-17       Impact factor: 4.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.